WHC est encore en dévelopement. Lisez ceci pour comprendre notre approche.
depiction of PJMPHNIQZUBGLI-UHFFFAOYSA-N.svg
tripsit

fentanyl

Vérifier sur tripsit

psychonaut

Fentanyl

Vérifier sur psychonaut

isomerdesign

Fentanyl

Vérifier sur isomerdesign

pubchem

Fentanyl

Vérifier sur pubchem

druglab

Fentanyl

Vérifier sur druglab

drugmap

Fentanyl

Vérifier sur drugmap

wiki

Fentanyl

Vérifier sur wiki

Data

InChI: InChI=1S/C22H28N2O/c1-2-22(25)24(20-11-7-4-8-12-20)21-14-17-23(18-15-21)16-13-19-9-5-3-6-10-19/h3-12,21H,2,13-18H2,1H3

Synonymes: Durogesic,Durotep MT,Fentanyl-100,Fentora,Propanamide, N-phenyl-N-(1-(2-phenylethyl)-4-piperidinyl)-, 437-38-7,N-Phenyl-N-(1-(2-phenylethyl)-4-piperidinyl)propanamide,N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]propanamide,DB00813,Fentanyl Transdermal System, Fentanyl-50,Fentanyl CII, Subsys,437-38-7,Fentanyl 1.0 mg/ml in Methanol,FENTANYL-HCl,N-(2-Phenethyl-4-piperidyl)-N-phenyl-propanamide,Duragesic-75,FENTANYL [VANDF], Fentanyl-37,HSDB 3329,FENTANYL [INN], Fentanyl-75,IONSYS,Q407541,DSSTox_CID_3049,1-(2-Phenylethyl)-4-(N-propananilido)piperidine,Fentanila,NCGC00168252-01,Fentanila [INN-Spanish],CHEMBL596,PROPANAMIDE, N-PHENYL-N-(1-(2-PHENYLETHYL)-4-PIPERIDINYL), Fentanil,FENTANYL [HSDB],Duragesic-25,Oprea1_152073,Fentanyl solution, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material,Fentanyl-75, Fentanil [DCIT],N-(1-Phenylethyl-4-piperidinyl)propionanilide,L001275,AD-923,FENTANYL [EMA EPAR VETERINARY],PDSP2_000846,UF599785JZ, N-(1-Phenethylpiperidin-4-yl)-N-phenylpropionamide,D00320,CHEBI:119915,BDBM50008984, Matrifen,FENTANYL [EMA EPAR], Sentonil,Matrifen,Fentanyl-50, Abstral, Durogesic,Fentanil [DCIT],Subsys (TN),Tranq component fentanyl,DTXCID103049,N-(1-Phenethyl-piperidin-4-yl)-N-phenyl-propionamide(Fentanyl),EN-3267, Duragesic-100, Fentanila [INN-Spanish],Oprea1_207148,R 4263,Duragesic,Duragesic-100,Abstral-,FENTANYL [JAN],BIDD:GT0555,CS-7211, Duragesic-25,FENTANYL CII [USP-RS],Fendrop, Fentanila,BRN 0494484, Duragesic-50,Fentanyl solution, 100 mug/mL in methanol, ampule of 1 mL, certified reference material,HY-U00158,JNS020QD,N-(1-Phenethyl-piperidin-4-yl)-N-phenyl-propionamide,N-Phenyl-N-[1-(2-phenylethyl)-4-piperidinyl]propanamide #, Duragesic,Fentanyl-12, N-Phenethyl-4-(N-propionylanilino)piperidine,FENTANYL [EP MONOGRAPH], Fentanyl-25,Fentanyl (JAN/USP/INN), Fentanest,Fentanyl-25, Fentanyl-100,N-(1-(2-phenylethyl)-4-piperidinyl)-N-phenylpropanamide, Fentora,DSSTox_RID_76851, N-(1-Phenethyl-4-piperidyl)propionanilide,FENTANYL [WHO-DD],Fentanylum [INN-Latin],N02AB03,Duragesic (TN), Sublimase, Duragesic-12,SCHEMBL8804,1-Phenethyl-4-(N-phenylpropionamido)piperidine,Duragesic-12,N-(2-Phenethyl-4- piperidyl)propionanilide,Sentonil,DSSTox_GSID_23049,N-Phenethyl-4-(N-propionylanilino)piperidine, fentanyl (transmucosal film, pain), Auxilium Pharmaceuticals,Fentanest,Fentanylum,Fentanyl,N-(1-Phenethylpiperidin-4-yl)-N-phenylpropionamide, Sublimaze Preservative Free,Propanamide, N-phenyl-N-[1-(2-phenylethyl)-4-piperidinyl]-,AD 923,FENTANYL [USAN], Fentanyl-62,UNII-UF599785JZ, Phentanyl,Sublimaze,FENTANYL [USP MONOGRAPH],Sublimase,FENTANYL [GREEN BOOK],Durogesic d-trans,N-(1-Phenethyl-4-piperidyl)propionanilide,R4263,Fentanyl 0.1 mg/ml in Methanol,GTPL1626, IONSYS, Fentanyl Citrate Preservative Free,DTXSID9023049,N-(1-Phenethyl-4-piperidinyl)-N-phenylpropionamide, Duragesic-75,1-Phenethyl-4-N-propionylanilinopiperidine, Fentanyl-87, Fentanylum,Duragesic-50,Phentanyl,PDSP1_000860, 1-Phenethyl-4-N-propionylanilinopiperidine,IDS-NF-001,Recuvyra,FENTANYL [EP IMPURITY],Subsys,FENTANYL [MI], Lazanda, Fentanylum [INN-Latin],Fentanil,7V7,CAS-437-38-7,ZINC2522669, Actiq,En3267, Fentanyl Citrate,5-22-08-00049 (Beilstein Handbook Reference),PecFent,fent, Onsolis,fentanyl,Propionanilide, N-(1-phenethyl-4-piperidyl)-,Tox21_112611,EINECS 207-113-6, Sublimaze,Fentanyl [USAN:USP:INN:BAN],FENTANYL [MART.],FENTANYL [ORANGE BOOK], Fentanyl-12,Epitope ID:153507


Estimated data

Solubility: -3.873 (log(S) in mol/L prediction using SolTranNet)

Blood Brain Barrier Permeability: Yes (prediction using frontiersin.org)

Addictivity Prediction: 98.8% (prediction based on www.mdpi.com)

Similitudes

Voici une série de comparaisons visant à comprendre les propriétés de ce composé. Ce site est encore très expérimental et fait l'objet d'un développement actif. Veuillez vous référer à notre série d'articles d'articles pour bien comprendre notre approche et ses limites. Ces informations sont données à titre indicatif et ne doivent pas être interprétées comme des conseils médicaux.